Company’s Board of Directors nominated Michael Chang to serve as the Chairman of the Board

Announcement to Permit Competitive Conduct by Officers
June 27, 2019
Announcement of the status of implementation of the commitments during the up-listing at over-the-counter market
June 27, 2019
  1. Date of the board of directors resolution or date of occurrence of the change: Jun 27, 2019
  2. .Type of personnel (chairman or general manager): Chairman
  3. Name and resume of the replaced chairman: Michael Chang/Chairman of the Board, OBI Pharma Inc.
  4. Name and resume of the new chairman: Michael Chang/Chairman of the Board, OBI Pharma Inc.
  5. Type of the change (please enter: “resignation” ,“conge”, “tenure expired” ,“position adjustment” ,“dismissal”, “retirement”, “death” or “new appointment” ): Tenure expired
  6. Reason for the change: Re-election
  7. Effective date of the new appointment: Jun 27, 2019
  8. Any other matters that need to be specified: None